Business Development Specialist - West Coast

Enzymatics, a Qiagen Company
Job Location
San Francisco, CA
Job Description

Enzymatics, a Qiagen Company, is seeking a Business Development Specialist for an entry level role focusing on the West Coast region. This position is accountable for delivering accurate revenue forecast throughout the fiscal year, enabling the executive team to monitor business performance and drive decision making. The Business Development Specialist is required to maintain knowledge of competitor products and strategies, identifying and escalating competitor activities to the Executive team in an appropriate time bound manner.


Job performance will involve a variety of activities including:

  • Attain quarterly and annual revenue targets established from annual operating plans.
  • Deliver accurate and timely forecasts for their territory.
  • Drive profitable and sustainable revenue and margin growth.
  • Introduce new product ideas to internal partners.
  • Work collaboratively with Marketing and Sales Operations to minimize time to revenue.
  • Represent the company at relevant tradeshows.
  • Maintain and raise awareness of the competitive landscape in the markets served.
  • Additional duties as assigned.


  • Some experience selling life science reagents and solutions. Knowledge and experience of selling to the academic market segment a prerequisite. Business to business experience preferred.
  • Demonstrated technical knowledge of genomics based applications with experience of next generation sequencing and molecular diagnostic applications a necessity. A background in technical sales and support is preferred.
  • Working experience of CRM applications, with knowledge preferred.


  • Bachelor’s degree (B.A./B.S) from four year College or university preferred in Biology or similar field and/or combination of experience and training
How to Apply

Please submit cover letter, resume and salary expectations to [email protected]

About Our Organization

Enzymatics is a leading producer of reagents, kits, and assays that enable our customers worldwide to transform patient diagnosis, treatment, and life science research. Our business units include: Reagents, Supply Chain Solutions, Applied Science.

A part of the proposed tax bill in the US could make tuition waivers taxable, Vox reports.

The New York Times reports that only a subset of STEM worker are in demand.

US News & World Report says students pursuing STEM degrees should consider what they are getting into.

New study finds bias against female lecturers among student course evaluations, the Economist reports.